Epilepsy & seizure disorders decisions — 2025

The Board granted an effective date of November 22, 2022, for the grant of service connection for tonic-clonic seizures and an initial 40 percent evaluation. Special monthly compensation based on aid and attendance was denied.

The Board granted service connection for the Veteran's focal motor seizures and tremors, which were related to his ACDUTRA service at Camp Lejeune. The claims for malignant degenerative disc disease, systemic sclerosis, and gadolinium-induced nephrogenic systemic are remanded for further examination.

The Board denied the Veteran's claims for earlier effective dates for service connection for TBI, psychomotor epilepsy, and migraines.

The Board denied the veteran's claims for increased ratings for erectile dysfunction, epilepsy, bowel dysfunction, and degenerative joint disease of the lumbar spine with intervertebral disc syndrome.

The Board denied the veteran's claims for earlier effective dates and higher ratings for various service-connected conditions, except for a separate 30% rating for Parkinson's disease with right upper extremity tremor and a separate 20% rating for right lower extremity tremor.

The Board denied the claims for service connection for a seizure disorder, vertigo, and traumatic brain injury as there is no evidence of these conditions during or shortly after service. The claims for bladder incontinence, migraine headaches, and right thumb pain were remanded for further development.

The Board remands the matter for an adequate medical opinion regarding whether the Veteran's service-connected disabilities aggravated any of the conditions that directly caused his death.

The Board granted an effective date of August 14, 2023, for the grant of a 70 percent disability rating for PTSD but denied earlier effective dates for service connection for psychomotor epilepsy and paroxysmal atrial tachycardia with systolic heart murmur.

The Board remands the matter to obtain a VA medical opinion regarding whether the Veteran's reported fatigue and behavioral changes are related to her seizure medication.

The Board denied increased ratings for generalized seizure disorder, chronic sinusitis, deviated nasal septum, and scars, but granted increased ratings of 20 percent for degenerative joint disease in the left and right ankles.

The Board remands the claims for further development to ensure that the severity of the Veteran's symptoms is accurately assessed without considering the ameliorative effects of his medication.

The Board remands the matter of entitlement to service connection for seizures, to include as due to an undiagnosed illness, for further evidentiary development.

The Board restored the 60% rating for epileptic seizure disorder and granted an increased disability rating of 80%.

The Board remands the claim for an increased rating for bilateral hearing loss due to a pre-decisional duty to assist error, and dismisses the service connection claim for seizures as it has been fully granted.

The Veteran's service-connected disabilities have prevented him from working since September 5, 2017, and he is entitled to a total disability rating for individual unemployability (TDIU) effective that date.